LIFECORE BIOMEDICAL INC DE
For the period ended May 28, 2023. Filed Mar 20, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 20, 2024
LFCR$6.36-0.6%Stored close · as of Nov 6, 2026
Opening this filing…